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Inﬂammation within the brain (neuroinﬂammation) has been associated with a number of 
neurodegenerative diseases, including Alzheimerʼs disease (AD) (Solito et al., 2012). Within the brain, 
inﬂammation is deﬁned broadly as prolonged activation of the brainʼs immune cells, known as glial 
cells. Excessive activation of glial cells within the brains of AD patients is a hallmark of the disease, 
however the mechanism by which this contributes to disease pathology is relatively unclear (Jo et al., 
2014). Recently, studies have shown that glial cells, known as astrocytes, are able to synthesize and 
release the inhibitory neurotransmitter GABA (Charles et al., 2003). Further, microglia cells, the primary 
immunocompetent cells of the brain, have been shown to be GABAceptive cells, which express GABA
(B) type receptors (Kuhn et al., 2004). Early characterizations of AD ﬁrst described alterations in 
astrocyte location and activation in the disease and interestingly, differences in the total abundance of 
GABA within the brains of AD patients have recently been reported. Combined, these data provide 
support for the hypothesis that astrocytes regulate microglia activity through the release of GABA acting 
at GABA(B) type receptors. The activation of GABA(B) on microglia may serve to reduce the activation 
status of these microglia, thereby reducing the number of pro-inﬂammatory cytokines present within the 
brain (Streit et al., 2002). In the present study, we examined the effects of the GABA(B) agonist 
baclofen on chronic inﬂammation in rodents administered lipopolysaccharide (LPS). LPS is a bacterial 
endotoxin derived from the cell wall of gram-negative bacteria and is capable of mounting an immune 
response through the activation of toll-like receptor 4 (TLR4). Our data indicate that the administration 
of baclofen initially attenuated the pyrogenic effects of LPS administration, though this effect was lost 
after two weeks of injections. The administration of baclofen also rescued deﬁcits in spatial learning and 
memory seen in animals chronically administered LPS. Furthermore, a signiﬁcant increase in the total 
abundance of AB oligomers, believed to play a role in the pathology of AD, was seen in the brains of 
animals chronically administered LPS. Together, these data provide evidence that the modulation of 
GABA(B) receptor function altered the immune response evoked by activation of TLR4. These data 
also provide support for a potential role of GABA(B) in modulating aberrant immune activity seen in AD 
populations.!
EXPERIMENTAL PROCEDURE!
Subjects:!
30 male Sprague Dawley rodents (n=30) were used in this experiment. Subjects were divided into three 
groups (n=10/group) and randomly assigned to one of three treatment schedules: Saline-Saline 
(control), LPS-Saline (LPS), or LPS-Baclofen (LPS-Bac). All animals were individually housed in a 
standard animal facility with a 12-12 hour light, dark cycle with food and water available ad libitum 
throughout the course of the experiment. All procedures were performed in accordance with the 
institutional Animal Care and Use Committee and NIH guidelines. !
Drug Administration:!
As part of a larger experiment, stereotaxic surgeries were performed on all animals under aseptic 
conditions and ketamine/dexmedatomidine anesthesia. 8mL of artiﬁcial cerebrospinal ﬂuid (ACSF) was 
slowly infused into each lateral ventricle using the stereotaxic coordinates 0.7mm posterior, 1.4mm 
lateral to Bregma, and 3.5 mm ventral to the surface of the skull. Following a recovery period of one 
week after surgeries, animals received intraperitoneal (i.p) injections of LPS (0.5mg/mL/kg) or saline 
(1mL/kg) twice a week for seven weeks for a total of 14 injections. Four hours following LPS or Saline 
injections, animals received i.p. injections of baclofen (1mg/mL/kg) or saline (1mL/kg) resulting in the 
three treatment groups: Saline-Saline (control), LPS-Saline (LPS), and LPS-Baclofen (LPS-Bac).!
Temperatures:!
To ensure an immune response was evoked by the administration of LPS, rectal temperatures were 
tracked prior to drug administration and at 1, 2, and 3-day intervals post injection throughout the course 
of the experiment. Following the last injection, animals were given three weeks for temperatures to 
return to baseline prior to behavioral testing. !
Morris Water Task:!
The Morris water task was conducted in a white circular tank, 1.8 m in diameter, 75 cm in height, and 
4.7 mm in thickness. To mask the hidden platform, each morning the water was made opaque with the 
addition of white non-toxic paint. For each subject, a 10cm x 10cm square platform was placed in the 
center of one of the four quadrants of the tank, 1.5 cm below the water. At the start of each trial, rats 
were placed into the maze and given sixty seconds to ﬁnd the hidden platform located below the 
surface of the water. If after sixty seconds the animal was unsuccessful in locating the hidden platform, 
a trained experimenter guided the animal to the hidden platform. Once reaching the platform, animals 
were given twenty seconds to orient themselves to the distal spatial cues. Each animal performed four 
trials for each day of experimental testing. Twenty-four hours after the control group reached an 
average latency of ten seconds, a single probe trial was conducted in which the platform was removed 
from the maze and selective search behavior was recorded for each animal. Following the probe trial, 
two days of visible training in which the hidden platform was replaced with a visible platform were 
conducted in order to detect any visual or motor deﬁcits. !
SDS Page/Western Blot:!
Tissue was prepared for western blotting as previously described (Sabbagh et al., 2013). For each 
sample, 20 micrograms of protein were loaded at 10% SDS-PAGE gels and proteins were separated by 
molecular weight through electrophoresis. Proteins were then transferred to nitrocellulose membranes 
and blocked in a solution of 5% milk to prevent non-speciﬁc antibody binding. Following blocking, 
membranes were incubated overnight in primary antibody (rabbit Aβ, 1:1000, Cell Signaling; mouse β-
actin, 1:20000, ProteinTech) at 4°C. Following overnight incubation, membranes were washed and 
placed into secondary antibody solution (IR dye anti-rabbit 800, 1:5000, Li-Cor; IR dye anti-mouse 680, 
1:10000, LiCor) for 2 hours. Membranes were imaged using the Odyssey CLx Infrared Imaging System 
and band intensity was obtained for each target of interest. Each sample was run in duplicate with β-
actin to normalize protein levels. !
RESULTS!
CONCLUSION!
Ø  Baclofen attenuated the pyrogenic response evoked through the 
administration of LPS .!
Ø  Baclofen rescued learning and memory deﬁcits seen in animals 
administered  LPS.!
Ø  LPS and LPS-Bac animals show a signiﬁcant increase in total Aβ 
oligomeric protein levels. !
Ø  Combined, these data provide support for the role of the GABA (B) 
receptor in modulating chronic neuroinﬂammation. !
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Total Aβ oligomeric protein levels were signiﬁcantly elevated in animals 
administered LPS. No differences were seen between LPS and LPS-Bac 
animals. !
Figure 4. Protein levels proportion to control (±SEM) in hippocampal tissue collected from animals. (* p < 0.05) 
Representative Western Blot image. !
Administration of baclofen rescued LPS-induced deﬁcits in learning and memory in 
the Morris water task. No differences were seen in visible performance, speed or 
percent thigmotaxis between animals.!
Figure 3. Mean proportion of time in quadrant and average number of annulus crossings (±SEM) during the probe trial. (*p < 
0.05 compared to controls)!
Administration of baclofen attenuated the pyrogenic effects of chronic LPS.!
Figure 1. Mean temperatures immediately prior to injections and at 1, 2, and 3 post-injection day intervals. (*p < 0.05 compared to 
controls). Error bars denoted as ± Standard Error of Mean (SEM). 
Figure 2. Mean latency, swim speed, and percent thigmotaxis (±SEM) for animals in the Morris water task. (*p < 0.05 compared to 
controls)!
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In the Morris water task probe trial, all groups spent signiﬁcantly more 
time in the target quadrant. Only controls showed a signiﬁcant increase 
in the number of annulus crossings.!
